Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients With Diabetic Macular Edema

NCT02121262 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02121262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02121262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients With Diabetic Macular Edema
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
January 8, 2016
Completion date
November 1, 2019
Enrollment
284 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema